Farzan Rastinejad

3.6k total citations · 2 hit papers
13 papers, 2.9k citations indexed

About

Farzan Rastinejad is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Farzan Rastinejad has authored 13 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Farzan Rastinejad's work include Cancer-related Molecular Pathways (6 papers), RNA modifications and cancer (3 papers) and Cancer Research and Treatments (3 papers). Farzan Rastinejad is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), RNA modifications and cancer (3 papers) and Cancer Research and Treatments (3 papers). Farzan Rastinejad collaborates with scholars based in United States, Germany and France. Farzan Rastinejad's co-authors include Peter J. Polverini, Noël Bouck, Michael J. Morin, Barbara A. Foster, William A. Frazier, Deborah J. Good, R.S. Lemons, Michelle M. Le Beau, Wenge Wang and Wafik S. El‐Deiry and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Farzan Rastinejad

13 papers receiving 2.8k citations

Hit Papers

A tumor suppressor-dependent inhibitor of angiogenesis is... 1990 2026 2002 2014 1990 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.
    1990 854 citations Deborah J. Good, Peter J. Polverini et al. Proceedings of the National Academy of Sciences profile →
  2. Pharmacological Rescue of Mutant p53 Conformation and Function
    1999 647 citations Barbara A. Foster, Michael J. Morin et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farzan Rastinejad United States 13 2.2k 1.0k 732 338 280 13 2.9k
Sharon Banin United Kingdom 8 1.6k 0.7× 1.0k 1.0× 447 0.6× 137 0.4× 398 1.4× 11 2.0k
Igor Garkavtsev United States 25 2.9k 1.3× 1.2k 1.2× 1.2k 1.6× 185 0.5× 251 0.9× 32 4.1k
Douglas Woods United States 11 2.0k 0.9× 1.3k 1.3× 383 0.5× 162 0.5× 285 1.0× 11 2.5k
Saadia A. Karim United Kingdom 22 1.8k 0.8× 1.6k 1.6× 725 1.0× 241 0.7× 724 2.6× 34 3.3k
J H Pierce United States 17 1.5k 0.7× 1.0k 1.0× 269 0.4× 130 0.4× 211 0.8× 23 2.3k
Rónán C. O’Hagan United States 18 2.2k 1.0× 1.1k 1.1× 458 0.6× 154 0.5× 323 1.2× 30 3.1k
Yohko Nakamura Japan 30 1.7k 0.8× 537 0.5× 702 1.0× 95 0.3× 330 1.2× 86 2.4k
Steve Coats United States 13 1.6k 0.7× 1.4k 1.4× 300 0.4× 132 0.4× 392 1.4× 18 2.3k
Berit B. Tysnes Norway 22 1.1k 0.5× 655 0.6× 412 0.6× 96 0.3× 379 1.4× 29 1.9k
Naira V. Margaryan United States 28 2.1k 0.9× 1.1k 1.1× 720 1.0× 67 0.2× 492 1.8× 57 2.8k

Countries citing papers authored by Farzan Rastinejad

Since Specialization
Citations

This map shows the geographic impact of Farzan Rastinejad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzan Rastinejad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzan Rastinejad more than expected).

Fields of papers citing papers by Farzan Rastinejad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farzan Rastinejad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzan Rastinejad. The network helps show where Farzan Rastinejad may publish in the future.

Co-authorship network of co-authors of Farzan Rastinejad

This figure shows the co-authorship network connecting the top 25 collaborators of Farzan Rastinejad. A scholar is included among the top collaborators of Farzan Rastinejad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farzan Rastinejad. Farzan Rastinejad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bassett, Emily, Wenge Wang, Farzan Rastinejad, & Wafik S. El‐Deiry. (2008). Structural and Functional Basis for Therapeutic Modulation of p53 Signaling. Clinical Cancer Research. 14(20). 6376–6386. 49 indexed citations
2.
Wischhusen, Jörg, Ulrike Naumann, Hideaki Ohgaki, Farzan Rastinejad, & Michael Weller. (2003). CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene. 22(51). 8233–8245. 134 indexed citations
3.
Wang, Wenge, Rishu Takimoto, Farzan Rastinejad, & Wafik S. El‐Deiry. (2003). Stabilization of p53 by CP-31398 Inhibits Ubiquitination without Altering Phosphorylation at Serine 15 or 20 or MDM2 Binding. Molecular and Cellular Biology. 23(6). 2171–2181. 119 indexed citations
4.
Wang, Wenge, Farzan Rastinejad, & Wafik S. El‐Deiry. (2003). Restoring p53-Dependent Tumor Suppression. Cancer Biology & Therapy. 2(sup1). 54–62. 54 indexed citations
5.
Takimoto, Rishu, Wenge Wang, David T. Dicker, et al.. (2002). The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis. Cancer Biology & Therapy. 1(1). 47–55. 104 indexed citations
6.
Foster, Barbara A., et al.. (1999). Pharmacological Rescue of Mutant p53 Conformation and Function. Science. 286(5449). 2507–2510. 647 indexed citations breakdown →
7.
Rastinejad, Farzan. (1993). Genetic complementation reveals a novel regulatory role for 3? untranslated regions in growth and differentiation. Cell. 72(6). 903–917. 214 indexed citations
8.
Rastinejad, Farzan, Michael J. Conboy, Thomas A. Rando, & Helen M. Blau. (1993). Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin. Cell. 75(6). 1107–1117. 171 indexed citations
9.
Peterson, Charlotte A., Mildred K. Cho, Farzan Rastinejad, & Helen M. Blau. (1992). β-Enolase is a marker of human myoblast heterogeneity prior to differentiation. Developmental Biology. 151(2). 626–629. 24 indexed citations
10.
Polverini, Peter J., Noël Bouck, & Farzan Rastinejad. (1991). Assay and purification of naturally occurring inhibitor of angiogenesis. Methods in enzymology on CD-ROM/Methods in enzymology. 440–450. 71 indexed citations
11.
Good, Deborah J., Peter J. Polverini, Farzan Rastinejad, et al.. (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.. Proceedings of the National Academy of Sciences. 87(17). 6624–6628. 854 indexed citations breakdown →
12.
Rastinejad, Farzan, Peter J. Polverini, & Noël Bouck. (1989). Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell. 56(3). 345–355. 362 indexed citations
13.
Aamodt, Eric J., et al.. (1989). Anti-tubulin monoclonal antibodies that bind to specific neurons in Caenorhabditis elegans. Journal of Neuroscience. 9(8). 2963–2972. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon Banin Breakdown of academic impact, for papers by Igor Garkavtsev Breakdown of academic impact, for papers by Douglas Woods Breakdown of academic impact, for papers by Saadia A. Karim Breakdown of academic impact, for papers by J H Pierce Breakdown of academic impact, for papers by Rónán C. O’Hagan Breakdown of academic impact, for papers by Yohko Nakamura Breakdown of academic impact, for papers by Steve Coats Breakdown of academic impact, for papers by Berit B. Tysnes Breakdown of academic impact, for papers by Naira V. Margaryan
Rankless by CCL
2026